Form Bio Co. Ltd. (377220) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Form Bio Co. Ltd. (377220) has a cash flow conversion efficiency ratio of -0.066x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.40 Billion ≈ $-950.36K USD) by net assets (₩21.22 Billion ≈ $14.38 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Form Bio Co. Ltd. market cap and net worth for the company's overall valuation and market capitalisation.
Form Bio Co. Ltd. - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Form Bio Co. Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Form Bio Co. Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Form Bio Co. Ltd. ranked by their cash flow conversion efficiency. Explore 377220 cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jet Freight Logistics Limited
NSE:JETFREIGHT
|
0.076x |
|
Tempest Security AB
ST:TSEC
|
0.232x |
|
CVS Group Plc
LSE:CVSG
|
0.145x |
|
Ovanti Ltd
AU:OVT
|
-0.245x |
|
OHEIM INT Co.Ltd
KQ:309930
|
0.298x |
|
Gullewa Ltd
AU:GUL
|
0.040x |
|
Pearl Gold AG
F:02P
|
N/A |
|
Mercury Industries Bhd
KLSE:8192
|
-0.235x |
Annual Cash Flow Conversion Efficiency for Form Bio Co. Ltd. (2019–2025)
The table below shows the annual cash flow conversion efficiency of Form Bio Co. Ltd. from 2019 to 2025. View 377220 live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩26.14 Billion ≈ $17.71 Million |
₩-10.07 Billion ≈ $-6.83 Million |
-0.385x | -28.71% |
| 2024-12-31 | ₩49.10 Billion ≈ $33.28 Million |
₩-14.70 Billion ≈ $-9.96 Million |
-0.299x | -7.96% |
| 2023-12-31 | ₩75.17 Billion ≈ $50.94 Million |
₩-20.85 Billion ≈ $-14.13 Million |
-0.277x | -1105.44% |
| 2022-12-31 | ₩87.96 Billion ≈ $59.61 Million |
₩-2.02 Billion ≈ $-1.37 Million |
-0.023x | -65.33% |
| 2021-12-31 | ₩84.43 Billion ≈ $57.22 Million |
₩-1.17 Billion ≈ $-796.13K |
-0.014x | -102.11% |
| 2020-12-31 | ₩23.64 Billion ≈ $16.02 Million |
₩15.61 Billion ≈ $10.58 Million |
0.660x | +218.72% |
| 2019-12-31 | ₩-10.21 Billion ≈ $-6.92 Million |
₩5.68 Billion ≈ $3.85 Million |
-0.556x | -- |
About Form Bio Co. Ltd.
From Bio Co.,Ltd manufactures and sells health related products in South Korea. It offers health functional food, health beauty, and living health products. The company also provides cosmetic products under the Mastina and HYCL brands. In addition, it operates an online platform to retail its products. The company was founded in 2006 and is headquartered in Suwon-si, South Korea.